Institutional EYE

Commentary on Corporate Governance Issues

April 30, 2020

ZEE Learn is unable to answer its investors’ questions. Its board and management have not provided the requisite leadership resulting in poor capital allocation decisions, including a botched-up acquisition. Plagued with high debt and weakening cash flows, the problems...

May 4, 2018

Fortis in its board meeting on 19 April 2017, constituted an expert advisory committee to evaluate the offers submitted to the board by the five bidders. The bidders, other than Manipal-TPG, were required to submit their final bids by 1 May 2018, while Manipal-TPG can...

April 24, 2018

The legitimacy of Fortis’ board is under question, and therefore, the legitimacy of the process it has adopted to sell the company is equally under question.  Investors have called for greater independence at the board level to support an objective decision-making proc...

April 19, 2018

Fortis Healthcare’s investors may be forgiven for wondering why everyone in the room is sitting scared. There are four competing bidders sitting across the table, yet all of them are holding back. Nor is the board pushing them hard. For investors the solution lies in p...

April 16, 2018

Gabbar Singh “Kitne aadmi thay?”

Kaliya “Sardar, do aadmi thay”

Gabbar Singh “Do aadmi? ….. aur tum teen….phir bhi waapas aagaye. Khali haath”

The above dialogue from Sholay still reverberate and if twisted, fit well with the current developments at Fortis Healthcare Limi...

Please reload

Categories
Please reload

Archive
Please reload

Older Posts (till 31 Dec'15)
Search by tags